Pinnacle Associates’s Renalytix plc American Depositary Shares RNLX Stock Holding History
Bought
Maintained
Sold
Other funds holding RNLX
Pinnacle Associates's RNLX Position: Q4 2024 in Review
Pinnacle Associates sold out of Renalytix plc American Depositary Shares (RNLX) in Q4 2024, closing a stake of 846,534 shares — an estimated $330K sold.
Pinnacle Associates first reported a position in RNLX in Q3 2020 and held it in 17 quarters. The position peaked at $3.79M in Q3 2021. 3 funds tracked by Wall St. Rank hold RNLX as of Q4 2024.
- Pinnacle Associates reported no remaining Renalytix plc American Depositary Shares position as of Q4 2024 after selling out during the quarter.
- Pinnacle Associates sold 846,534 Renalytix plc American Depositary Shares shares in Q4 2024, an estimated $330K.
- Pinnacle Associates first reported a position in Renalytix plc American Depositary Shares in Q3 2020 and held it in 17 quarters.
- Pinnacle Associates's Renalytix plc American Depositary Shares position peaked at $3.79M in Q3 2021.
- 3 funds tracked by Wall St. Rank held Renalytix plc American Depositary Shares as of Q4 2024.
Based on Pinnacle Associates's 13F filing for Q4 2024, filed 14 Feb 2025.